澜起科技(688008.SH):2023年员工持股计划拟募资不超2.5亿元
格隆汇4月14日丨澜起科技(688008.SH)公布2023年员工持股计划,员工持股计划的股票来源为公司回购专用账户回购的公司股票以及通过二级市场购买(包括但不限于大宗交易、集中竞价交易、协议转让、融资融券)等法律法规许可的方式获得的公司股票。本员工持股计划拟筹集资金总额不超过2.5亿元。
拟参加本次员工持股计划的员工总人数不超过60人,本员工持股计划的股票来源为公司回购专用账户回购的公司股票以及通过二级市场购买(包括但不限于大宗交易、集中竞价交易、协议转让、融资融券)等法律法规许可的方式获得的公司股票。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.